People: Zealand Pharma A/S (ZELA.CO)
Ms. Rosemary A. Crane has been Independent Vice Chairman of the Board at Zealand Pharma A/S since April 21, 2015. Ms. Rosemary Crane has been CEO of Mela Sciences (2013-2014) and Epocrates (2008-2011), besides having held a number of senior positions in Johnson & Johnson and BMS. She is Member of the Board of Teva Pharmaceutical Industries Ltd. and Edge Therapeutics. Rose has a BA in Communication from the State University of New York, MBA from Kent State University.
|Total Annual Compensation, DKK||400,000|
|Restricted Stock Award, DKK||--|
|Long-Term Incentive Plans, DKK||--|
|All Other, DKK||--|
|Fiscal Year Total, DKK||400,000|